Frondanol ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 97 | 潰瘍性大腸炎 | 1 |
97. 潰瘍性大腸炎
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05194007 (ClinicalTrials.gov) | February 19, 2022 | 18/11/2021 | Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease | A Pilot Randomized, Double-blind, Placebo-controlled Trial to Investigate the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease | Ulcerative Colitis Chronic Mild;Ulcerative Colitis Chronic Moderate;Crohn Colitis | Drug: Frondanol;Drug: Placebo | Mohammed Bin Rashid University of Medicine and Health Sciences | Mediclinic Middle East;Rashid Hospital;Dubai Health Authority | Recruiting | 18 Years | N/A | All | 100 | Phase 2/Phase 3 | United Arab Emirates |